JavaScript is disabled.
Some features may not work properly. For the best experience, please enable JavaScript in your browser.
Ledgeburg
Sign In
Loading...
News
Latest
Latest News
Stocks
Discover
Search Stocks
ETFs
Discover
Search ETFs
Funds
Discover
Search Funds
DNA Financials - Ginkgo Bioworks Holdings. Income & Cash Flow | Ledgeburg
DNA - Ginkgo Bioworks Holdings. Inc.
USD | NYSE | Healthcare
Summary
Summary DNA Stock
Financials
Financials DNA Stock
Loading...
Loading...
Income Statement
Income Statement DNA Stock
Balance Sheet
Balance Sheet DNA Stock
Cash Flow Statement
Cash Flow Statement DNA Stock
Loading...
Loading...
Home
Stocks
Ginkgo Bioworks Holdings. Inc. (DNA)
Financials
Financials of DNA
Loading...
Loading...
Loading...
Loading...
Revenue
$170.155M
Operating Income
$-315.278M
Net Income
$-312.763M
Share Count (Basic)
55.457676M
Operating Cash Flow
$-171.059M
Free Cash Flow
$-178.724M
Cash And Short-Term Equivalents
$422.62M
Total Debt
N/A
Annual
Quarterly
Revenue $USD
0
100M
200M
300M
400M
500M
FY2021
FY2022
FY2023
FY2024
Revenue $USD
0
10M
20M
30M
40M
50M
Q1 FY25
Q2 FY25
Q3 FY25
Q4 FY25
Annual
Quarterly
Net Income $USD
-2B
-1.5B
-1B
-500M
Annual
Quarterly
Margins
Gross
Operating
Net
-600%
-500%
-400%
-300%
-200%
FY2025
Q1 FY26
FY2021
FY2022
FY2023
FY2024
FY2025
Net Income $USD
-90M
-80M
-70M
-60M
Q1 FY25
Q2 FY25
Q3 FY25
Q4 FY25
Q1 FY26
FY2021
FY2022
FY2023
FY2024
FY2025
Margins
Gross
Operating
Net
-400%
-300%
-200%
-100%
0%
100%
Q1 FY25
Q2 FY25
Q3 FY25
Q4 FY25
Q1 FY26